Načítá se...
CTLA-4 correlates with immune and clinical characteristics of glioma
BACKGROUND: CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been examined. METHODS: We investigated the protein level...
Uloženo v:
| Vydáno v: | Cancer Cell Int |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945521/ https://ncbi.nlm.nih.gov/pubmed/31911758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-1085-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|